Apollo Medical Holdings Inc (AMN) SEC News Jan. 14, 2026, 14:01 UTC 0 1 comments (35% Negative) Apollo Medical Holdings Inc (AMN) Reports Q1 2026 Financial Results Comment Full text
Pulse Biosciences Inc (PLSE) SEC News Jan. 14, 2026, 14:00 UTC 0 1 comments (99% Neutral) Pulse Biosciences Inc (PLSE) Files Form 8-K Comment Full text
Intuitive Surgical Inc (ISRG) SEC News Jan. 14, 2026, 13:58 UTC 0 1 comments (80% Positive) Intuitive Surgical Inc (ISRG) Reports Q1 2026 Financial Results Comment Full text
ImmunityBio Inc (IBRX) SEC News Jan. 14, 2026, 13:42 UTC 0 1 comments (90% Positive) ImmunityBio Inc (IBRX) Provides Update on Inhibitors for combinatio Comment Full text
LivaNova PLC (LIVN) SEC News Jan. 14, 2026, 13:32 UTC 0 1 comments (99% Neutral) LivaNova PLC (LIVN) Announces Executive Departure Comment Full text
Aveanna Healthcare Holdings Inc (AVAH) SEC News Jan. 14, 2026, 13:30 UTC 0 1 comments (99% Neutral) Aveanna Healthcare Holdings Inc (AVAH) Reports Q1 2026 Financial Results Comment Full text
SciSparc Ltd. (SPRC) SEC News Jan. 14, 2026, 13:29 UTC 7 0 comments New Form 424B5 - SciSparc Ltd. Filed: 2026-01-14 AccNo: 0001213900-26-004172 Size: 316 KB Comment Full text
Immuneering Corporation (IMRX) SEC News Jan. 14, 2026, 13:10 UTC 0 1 comments Director Feinberg Peter 🟢 acquired 20.0K shares of Immuneering Corp (IMRX) at $4.35 Transaction Date: Jan 12, 2026 | Filing ID: 000008 Comment Full text
Establishment Labs Holdings Inc (ESTA) SEC News Jan. 14, 2026, 13:01 UTC 0 1 comments (99% Neutral) Establishment Labs Holdings Inc (ESTA) Files Form 8-K Comment Full text
RAPT Therapeutics Inc (RAPT) SEC News Jan. 14, 2026, 13:00 UTC 0 1 comments (10% Negative) RAPT Therapeutics Inc (RAPT) Announces Delay in opportunity Trials for ozureprubart Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment Comment Full text